romidepsin
Showing 26 - 50 of 58
Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Ketoconazole)
Completed
- Hematologic Malignancy
- Malignant Lymphoma
- Romidepsin
- Ketoconazole
-
Sarasota, Florida
- +2 more
Nov 14, 2019
Pancreatic Cancer Trial in Nashville (Romidepsin, Gemcitabine)
Completed
- Pancreatic Cancer
- Romidepsin
- Gemcitabine
-
Nashville, TennesseeSarah Cannon Research Institute
Oct 16, 2019
Multiple Myeloma Trial in United States (Bortezomib, Romidepsin)
Prostate Cancer, Metastases Trial (Romidepsin)
Completed
- Prostate Cancer
- Metastases
- Romidepsin
- (no location specified)
Nov 14, 2019
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell
Terminated
- Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
- +13 more
- carfilzomib
- +2 more
-
Chicago, IllinoisNorthwestern University
Jul 24, 2019
Peripheral T-cell Lymphoma Trial in Worldwide (Romidepsin)
Completed
- Peripheral T-cell Lymphoma
- Romidepsin
-
La Jolla, California
- +89 more
Jan 29, 2020
Lymphoma, T-cell, Peripheral Trial in Japan (Romidepsin)
Completed
- Lymphoma, T-cell, Peripheral
- Romidepsin
-
Nagoya, Aichi, Japan
- +16 more
Jan 28, 2019
Multiple Myeloma Trial in New York (Romidepsin, pomalidomide, Dexamethasone)
Terminated
- Multiple Myeloma
- Romidepsin
- +2 more
-
New York, New YorkWeill Cornell Medical College
May 31, 2018
HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer Trial in Philadelphia (Romidepsin, Abraxane)
Terminated
- HER2-negative Breast Cancer
- +4 more
- Romidepsin
- Abraxane
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 4, 2017
HIV Trial in Badalona, Barcelona (MVA.HIVconsv vaccine, Romidepsin)
Completed
- HIV
- MVA.HIVconsv vaccine
- Romidepsin
-
Badalona, Barcelona, Spain
- +1 more
Jan 16, 2018
Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Worldwide (Alisertib, Pralatrexate,
Completed
- Relapsed Peripheral T-Cell Lymphoma
- Refractory Peripheral T-Cell Lymphoma
- Alisertib
- +3 more
-
Birmingham, Alabama
- +151 more
Jul 6, 2018
GVHD Trial in New Brunswick (romidepsin, laboratory biomarker analysis)
Terminated
- Graft Versus Host Disease
- romidepsin
- laboratory biomarker analysis
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Feb 13, 2017
Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma Trial (romidepsin)
Completed
- Adult Alveolar Soft-part Sarcoma
- +19 more
- romidepsin
- (no location specified)
May 18, 2017
HIV I Infection Trial in Aarhus N (Romidepsin, Vacc-4x, rhuGM-CSF)
Completed
- HIV I Infection
- Romidepsin
- +2 more
-
Aarhus N, DenmarkAarhus University Hospital, Skejby Sygehus
Jan 11, 2017
Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)
Completed
- Cutaneous T Cell Lymphoma
- Peripheral T Cell Lymphoma
- Romidepsin
-
Scottsdale, Arizona
- +12 more
Apr 13, 2017
Long-term Use of Romidepsin in Patients With CTCL
Completed
- Cutaneous T-cell Lymphoma
- Romidepsin
-
Chicago, IllinoisNorthwestern University Dermatology Department
Mar 10, 2016
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +7 more
- romidepsin
-
Chicago, Illinois
- +1 more
Dec 3, 2015
Lymphoma Trial run by the NCI (romidepsin)
Completed
- Lymphoma
- romidepsin
-
Bethesda, MarylandMedicine Branch
Apr 28, 2015
DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Bronx (Romidepsin,
Completed
- DS Stage II Plasma Cell Myeloma
- +2 more
- Romidepsin
- Laboratory Biomarker Analysis
-
Bronx, New YorkMontefiore Medical Center - Moses Campus
Mar 16, 2015
Recurrent Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer Trial in Commack (drug, other,
Completed
- Recurrent Thyroid Cancer
- +2 more
- romidepsin
- +2 more
-
Commack, New YorkMemorial Sloan-Kettering Cancer Center at Suffolk
May 13, 2014
Recurrent Small Cell Lung Cancer Trial in Columbus (romidepsin, laboratory biomarker analysis)
Completed
- Recurrent Small Cell Lung Cancer
- romidepsin
- laboratory biomarker analysis
-
Columbus, OhioOhio State University
Apr 9, 2014
Histologically Proven Extranodal NKTcell Lymphoma Trial in Korea, Republic of (Romidepsin)
Completed
- Histologically Proven Extranodal NKTcell Lymphoma
- Romidepsin
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +3 more
Jul 29, 2013